Preliminary data on the oncological safety of autologous fat transfer (AFT) for total breast reconstruction from the BREAST trial

Per study protocol, loco-regional recurrence in the BREAST trial was analysed: no significant difference was observed between AFT-reconstruction and IBR-reconstruction. This study was underpowered for oncological endpoints, the population was too heterogeneous, and not all participants received recommended oncological care.